Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Craig

Showing results (221-230 of 302) with videos related to

Pageof 31
Sort By:
Journal of Translational Medicine|June 26, 2023
Novel method for highly multiplexed gene expression profiling of circulating tumor cells (CTCs) captured from the blood of women with metastatic breast cancerMorvarid Farhang Ghahremani, Kelly Kai Yin Seto, Woohyun Cho, et al.
Leukemia Research and Treatment|July 12, 2017
Evaluation of Serum Posaconazole Concentrations in Patients with Hematological Malignancies Receiving Posaconazole Suspension Compared to the Delayed-Release Tablet FormulationMorgan Belling, Abraham S Kanate, Alexandra Shillingburg, et al.
Antimicrobial Agents and Chemotherapy|May 20, 2015
Superior Serum Concentrations with Posaconazole Delayed-Release Tablets Compared to Suspension Formulation in Hematological MalignanciesAaron Cumpston, Ryan Caddell, Alexandra Shillingburg, et al.
BMC Neuroscience|March 27, 2009
Proteomic and functional analysis of NCS-1 binding proteins reveals novel signaling pathways required for inner ear development in zebrafishJessica A Petko, Nadine Kabbani, Colleen Frey, et al.
British Journal of Haematology|July 22, 2014
Phase II study of bortezomib in combination with rituximab, cyclophosphamide and prednisone with or without doxorubicin followed by rituximab maintenance in patients with relapsed or refractory follicular lymphomaMichael Craig, Wahid T Hanna, Fernando Cabanillas, et al.
American Journal of Obstetrics and Gynecology|February 4, 2012
Serum levels of the ovarian cancer biomarker HE4 are decreased in pregnancy and increase with ageRichard G Moore, Michael Craig Miller, Elizabeth E Eklund, et al.
Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention|October 17, 2020
Evaluation of the effectiveness, implementation and cost-effectiveness of the Stay One Step Ahead home safety promotion intervention for pre-school children: a study protocolElizabeth Orton, Michael Craig Watson, Mike Hayes, et al.
International Journal of Cancer|September 4, 2008
Prognostic value of Her-2/neu and DNA index for progression, metastasis and prostate cancer-specific death in men with long-term follow-up after radical prostatectomySumit Isharwal, Michael Craig Miller, Jonathan I Epstein, et al.
Antimicrobial Agents and Chemotherapy|January 30, 2016
Prospective, Controlled Study of Acyclovir Pharmacokinetics in Obese PatientsR Brigg Turner, Aaron Cumpston, Michael Sweet, et al.
Pharmacotherapy|November 12, 2021
A prospective study of filgrastim pharmacokinetics in morbidly obese patients compared with non-obese controlsAaron W Stewart, Alexandra Shillingburg, William Petros, et al.
Pageof 31

Showing results (221-230 of 302) with videos related to

Sort By:
Pageof 31
Journal of Translational Medicine|June 26, 2023
Novel method for highly multiplexed gene expression profiling of circulating tumor cells (CTCs) captured from the blood of women with metastatic breast cancerMorvarid Farhang Ghahremani, Kelly Kai Yin Seto, Woohyun Cho, et al.
Leukemia Research and Treatment|July 12, 2017
Evaluation of Serum Posaconazole Concentrations in Patients with Hematological Malignancies Receiving Posaconazole Suspension Compared to the Delayed-Release Tablet FormulationMorgan Belling, Abraham S Kanate, Alexandra Shillingburg, et al.
Antimicrobial Agents and Chemotherapy|May 20, 2015
Superior Serum Concentrations with Posaconazole Delayed-Release Tablets Compared to Suspension Formulation in Hematological MalignanciesAaron Cumpston, Ryan Caddell, Alexandra Shillingburg, et al.
BMC Neuroscience|March 27, 2009
Proteomic and functional analysis of NCS-1 binding proteins reveals novel signaling pathways required for inner ear development in zebrafishJessica A Petko, Nadine Kabbani, Colleen Frey, et al.
British Journal of Haematology|July 22, 2014
Phase II study of bortezomib in combination with rituximab, cyclophosphamide and prednisone with or without doxorubicin followed by rituximab maintenance in patients with relapsed or refractory follicular lymphomaMichael Craig, Wahid T Hanna, Fernando Cabanillas, et al.
American Journal of Obstetrics and Gynecology|February 4, 2012
Serum levels of the ovarian cancer biomarker HE4 are decreased in pregnancy and increase with ageRichard G Moore, Michael Craig Miller, Elizabeth E Eklund, et al.
Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention|October 17, 2020
Evaluation of the effectiveness, implementation and cost-effectiveness of the Stay One Step Ahead home safety promotion intervention for pre-school children: a study protocolElizabeth Orton, Michael Craig Watson, Mike Hayes, et al.
International Journal of Cancer|September 4, 2008
Prognostic value of Her-2/neu and DNA index for progression, metastasis and prostate cancer-specific death in men with long-term follow-up after radical prostatectomySumit Isharwal, Michael Craig Miller, Jonathan I Epstein, et al.
Antimicrobial Agents and Chemotherapy|January 30, 2016
Prospective, Controlled Study of Acyclovir Pharmacokinetics in Obese PatientsR Brigg Turner, Aaron Cumpston, Michael Sweet, et al.
Pharmacotherapy|November 12, 2021
A prospective study of filgrastim pharmacokinetics in morbidly obese patients compared with non-obese controlsAaron W Stewart, Alexandra Shillingburg, William Petros, et al.
Pageof 31